menu
    • menu

    Company profile for Bolt Biotherapeutics

    NEW Drugs in Dev: 7
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bolt Biotherapeutics is a vibrant biotechnology company actively developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Simulating Antibody Conjugates (ISAC). Located in the San Francisco Bay Area, Bolt is led by a team with extensive oncology drug development experience and is seeking bright, self-motivated individuals who share their passion for bringing novel and curative biotherapies to p...
    Bolt Biotherapeutics is a vibrant biotechnology company actively developing its novel Boltbody™ platform, a cancer immunotherapy that consists of Immune-Simulating Antibody Conjugates (ISAC). Located in the San Francisco Bay Area, Bolt is led by a team with extensive oncology drug development experience and is seeking bright, self-motivated individuals who share their passion for bringing novel and curative biotherapies to patients in need

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bolt BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    640 Galveston Drive Redwood City, CA 94063
    Telephone
    Telephone
    650.665.9295
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.boltbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bolt-biotherapeutics-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bolt Bio Reports 2025 Financials And Business Update
    Bolt Bio Reports 2025 Financials And Business Update

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255098/0/en/Bolt-Biotherapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Bolt Biotherapeutics To Participate In Upcoming March Conferences
    Bolt Biotherapeutics To Participate In Upcoming March Conferences

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243462/0/en/Bolt-Biotherapeutics-to-Participate-in-Upcoming-March-Conferences.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Bolt Biotherapeutics Reveals Q3 2025 Financials & Business
    Bolt Biotherapeutics Reveals Q3 2025 Financials & Business

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186772/0/en/Bolt-Biotherapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Bolt Bio Updates BDC-4182, Extends Cash Runway To 2027
    Bolt Bio Updates BDC-4182, Extends Cash Runway To 2027

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159924/0/en/Bolt-Biotherapeutics-Provides-Update-on-BDC-4182-and-Extends-Cash-Runway-into-2027.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Bolt Biotherapeutics Reports Q2 2025 Financials, Business Update
    Bolt Biotherapeutics Reports Q2 2025 Financials, Business Update

    14 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/14/3133839/0/en/Bolt-Biotherapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    14 Aug 2025
    Share Share
    Bolt Biotherapeutics Reports Q1 2025 Results and Business Update
    Bolt Biotherapeutics Reports Q1 2025 Results and Business Update

    12 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/12/3079551/0/en/Bolt-Biotherapeutics-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 May 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search